Literature DB >> 18720262

High mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) in Kawasaki disease.

T Hoshina1, K Kusuhara, K Ikeda, Y Mizuno, M Saito, T Hara.   

Abstract

OBJECTIVE: To investigate whether two proinflammatory cytokines, high mobility group box 1 (HMGB1) and macrophage migration inhibitory factor (MIF) are involved in the development of Kawasaki disease (KD).
METHODS: Twenty-seven patients with KD were included in this study. Eleven patients with sepsis and 28 healthy children served as controls. Serum levels of HMGB1 and MIF were measured by corresponding enzyme-linked immunosorbent assay (ELISA) kits, respectively. Real-time polymerase chain reaction (PCR) was used to quantify the expression levels of genes encoding receptor for advanced glycation end-products (RAGE), an HMGB1 receptor, and CD74, an MIF receptor in peripheral blood mononuclear cells (PBMCs).
RESULTS: Serum levels of HMGB1 and MIF in KD patients were the highest in the early acute phase and gradually decreased after defervescence. Serum HMGB1 and MIF levels in KD patients were significantly higher than those in controls (HMGB1, p<0.001; MIF, p<0.01). The expression levels of the RAGE gene and CD74 gene in KD patients were significantly higher than those in controls (RAGE, p<0.001; CD74, p<0.01).
CONCLUSION: These data suggest that HMGB1 and MIF play an important role in immune responses in KD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18720262     DOI: 10.1080/03009740802144143

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  19 in total

Review 1.  HMGB1: a multifunctional alarmin driving autoimmune and inflammatory disease.

Authors:  Helena Erlandsson Harris; Ulf Andersson; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2012-01-31       Impact factor: 20.543

Review 2.  Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum.

Authors:  G A Ramirez; N Maugeri; M G Sabbadini; P Rovere-Querini; A A Manfredi
Journal:  Clin Exp Immunol       Date:  2014-02       Impact factor: 4.330

3.  Interleukin-33/ST2 Axis as Potential Biomarker and Therapeutic Target in Kawasaki Disease.

Authors:  Seigo Okada; Hiroki Yasudo; Yuji Ohnishi; Chie Matsuguma; Reiji Fukano; Takahiro Motonaga; Takako Waniishi; Shunji Hasegawa
Journal:  Inflammation       Date:  2022-10-08       Impact factor: 4.657

Review 4.  Role of High Mobility Group Box 1 in Cardiovascular Diseases.

Authors:  Souad Belmadani; Khalid Matrougui
Journal:  Inflammation       Date:  2022-04-07       Impact factor: 4.657

Review 5.  High-mobility group box 1 (HMGB1) in childhood: from bench to bedside.

Authors:  Valeria Chirico; Antonio Lacquaniti; Vincenzo Salpietro; Caterina Munafò; Maria Pia Calabrò; Michele Buemi; Teresa Arrigo; Carmelo Salpietro
Journal:  Eur J Pediatr       Date:  2014-05-09       Impact factor: 3.183

Review 6.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

7.  High mobility group box 1 levels in large vessel vasculitis are not associated with disease activity but are influenced by age and statins.

Authors:  Alexandre W S de Souza; Kornelis S M van der Geest; Elisabeth Brouwer; Frederico A G Pinheiro; Ana Cecília Diniz Oliveira; Emília Inoue Sato; Luis Eduardo C Andrade; Marc Bijl; Johanna Westra; Cees G M Kallenberg
Journal:  Arthritis Res Ther       Date:  2015-06-12       Impact factor: 5.156

8.  Prednisolone Suppresses the Extracellular Release of HMGB-1 and Associated Inflammatory Pathways in Kawasaki Disease.

Authors:  Kentaro Ueno; Yuichi Nomura; Yasuko Morita; Yoshifumi Kawano
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

Review 9.  Epigenetics in Kawasaki Disease.

Authors:  Kaushal Sharma; Pandiarajan Vignesh; Priyanka Srivastava; Jyoti Sharma; Himanshi Chaudhary; Sanjib Mondal; Anupriya Kaur; Harvinder Kaur; Surjit Singh
Journal:  Front Pediatr       Date:  2021-06-25       Impact factor: 3.418

Review 10.  Nuclear antigens and auto/alloantibody responses: friend or foe in transplant immunology.

Authors:  Toshiaki Nakano; Chao-Long Chen; Shigeru Goto
Journal:  Clin Dev Immunol       Date:  2013-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.